标题
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2
作者
关键词
-
出版物
KIDNEY INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-08-22
DOI
10.1016/j.kint.2022.07.025
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2
- (2021) Prince Singh et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hepatic Lactate Dehydrogenase A is an RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
- (2021) Gema Ariceta et al. Kidney International Reports
- A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3
- (2021) Cristina Martin-Higueras et al. KIDNEY INTERNATIONAL
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria.
- (2021) Bernd Hoppe et al. KIDNEY INTERNATIONAL
- Primary hyperoxaluria type 2 successfully treated with combined liver‐kidney transplantation after failure of isolated kidney transplantation
- (2020) Arnaud Del Bello et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Endpoints for Clinical Trials in Primary Hyperoxaluria
- (2020) Dawn S. Milliner et al. Clinical Journal of the American Society of Nephrology
- Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity
- (2019) Kyle D. Wood et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up
- (2019) Sander F. Garrelfs et al. KIDNEY INTERNATIONAL
- Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
- (2018) Chengjung Lai et al. MOLECULAR THERAPY
- Metabolic profile and impact of diet in patients with primary hyperoxaluria
- (2018) Roswitha Siener et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- An institutional experience of pre-emptive liver transplantation for pediatric primary hyperoxaluria type 1
- (2016) Shirin Elizabeth Khorsandi et al. PEDIATRIC TRANSPLANTATION
- Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure
- (2015) F. Zhao et al. Clinical Journal of the American Society of Nephrology
- Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
- (2015) K. Hopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type
- (2014) Giorgia Mandrile et al. KIDNEY INTERNATIONAL
- NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
- (2013) Felix Knauf et al. KIDNEY INTERNATIONAL
- Primary Hyperoxaluria
- (2013) Pierre Cochat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hereditary causes of kidney stones and chronic kidney disease
- (2013) Vidar O. Edvardsson et al. PEDIATRIC NEPHROLOGY
- Primary hyperoxalurias: Disorders of glyoxylate detoxification
- (2012) Eduardo Salido et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C
- (2012) George J. Schwartz et al. KIDNEY INTERNATIONAL
- An update on primary hyperoxaluria
- (2012) Bernd Hoppe Nature Reviews Nephrology
- Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
- (2012) P. Cochat et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions
- (2010) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Excellent renal function and reversal of nephrocalcinosis 8 years after isolated liver transplantation in an infant with primary hyperoxaluria type 1
- (2010) Mónica Galanti et al. PEDIATRIC NEPHROLOGY
- Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
- (2009) Jérôme Harambat et al. KIDNEY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started